Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up.
Ulas Höke, Dominique Auger, Joep Thijssen...
https://pubmed.ncbi.nlm.nih.gov/24449717Actively Recruiting
Led by Haiyan Wang · Updated on 2025-04-30
200
Participants Needed
1
Research Sites
8 weeks
Total Duration
Researchers are studying tricuspid regurgitation (TR), a common complication after implantation of cardiac implantable electronic devices (CIEDs) like pacemakers. Severe TR is linked to higher risks of heart failure hospitalization and death, greatly affecting quality of life. This observational study aims to identify factors predicting worsening TR and adverse outcomes in patients with different pacing methods, to guide care for those at high risk. The study reviews patients who had pacemaker implantation between 2015 and 2025, categorized by pacing type: right ventricular, conduction system, or biventricular pacing. It analyzes TR progression defined as an increase of at least half a grade. Assessments include 3D echocardiography to understand TR mechanisms, fluoroscopic analysis of pacemaker leads, and evaluation of device-related complications like lead dislodgement or infection, along with heart failure readmissions. Participants' data from up to one year of follow-up will be analyzed to measure TR progression and heart failure hospitalizations. The research includes clinical evaluations, imaging studies, and device parameter measurements. This approach helps monitor how pacing modes affect TR and outcomes, aiming to improve management strategies for patients with implanted cardiac devices.
CONDITIONS
Pacemaker-related Tricuspid Regurgitation Progression and Long-term Outcomes
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Procedure day
Participants undergo pacemaker implantation using one of the pacing methods: right ventricular pacing, conduction system pacing, or biventricular pacing.
1 visit (in-person)
Duration - Mean follow-up of 1 year
Participants are observed over time to assess tricuspid regurgitation progression and clinical outcomes including heart failure readmission and device-related complications.
Regular follow-up visits during the year as per clinical care
Total: 1 location
1
The First Affiliated Hospital of Shandong First Medical University
Jinan, China, 250000
Actively Recruiting
H
Haiyan Wang, MD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Ulas Höke, Dominique Auger, Joep Thijssen...
https://pubmed.ncbi.nlm.nih.gov/24449717Xiaofei Li, Xiaohan Fan, Qian Wang...
https://pubmed.ncbi.nlm.nih.gov/37649400Xiaofei Li, Haojie Zhu, Xiaohan Fan...
https://pubmed.ncbi.nlm.nih.gov/35278699